Journal article icon

Journal article

Endpoints for trials in Alzheimer's disease: a European task force consensus.

Abstract:

Harmful consequences in health status caused by disease are referred to as outcomes, and in clinical studies the measures of these outcomes are called endpoints. A major challenge when deciding on endpoints is to represent the outcomes of interest accurately, and the accuracy of such representation is assessed through validation. Complex diseases like Alzheimer's disease have many different and interdependent outcomes. We present a consensus for endpoints to be used in clinical trials in Alzh...

Expand abstract
Publication status:
Published

Actions


Access Document


Journal:
Lancet. Neurology More from this journal
Volume:
7
Issue:
5
Pages:
436-450
Publication date:
2008-05-01
DOI:
EISSN:
1474-4465
ISSN:
1474-4422
Language:
English
Keywords:
Pubs id:
pubs:60826
UUID:
uuid:228f199e-6dae-4032-98b7-68d2f5d884c5
Local pid:
pubs:60826
Source identifiers:
60826
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP